专利检索 ap:("ISIS PHARMACEUTICALS, INC." OR "The Baylor College of Medicine") AND inv:"O'MALLEY, BERT, W." 第 1 页

1.

发明公开
ANTISENSE MODULATION OF SRC-1 EXPRESSION 审中-公开
标题翻译：抗原调制剂SRC-1表达

公开(公告)号：EP1358199A2

公开(公告)日：2003-11-05

申请号：EP01988188.7

申请日：2001-11-26

申请人： ISIS PHARMACEUTICALS, INC. , The Baylor College of Medicine

发明人： O'MALLEY, BERT, W. , BENNETT, C., Frank , COWSERT, Lex, M.

IPC分类号： C07H21/04 , C12Q1/68 , C12N15/85

CPC分类号： C12N15/113 , A61K38/00 , C12N2310/315 , C12N2310/321 , C12N2310/3341 , C12N2310/341 , C12N2310/346 , Y02P20/582 , C12N2310/3525

摘要： Antisense compounds, compositions and methods are provided for modulating the expression of SRC-1. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding SRC-1. Methods of using these compounds for modulation of SRC-1 expression and for treatment of diseases associated with expression of SRC-1 are provided.